GO
Loading...

Drug Retail

More

  • April 10- Rite Aid Corp, the third-largest U.S. drugstore operator, forecast fiscal 2015 sales above analysts' estimates as it benefits from the launch of new generic drugs and enrolls more customers in its loyalty programs.

  • Another profitable quarter, Rite Aid breaks out Thursday, 10 Apr 2014 | 8:27 AM ET

    Rite Aid has left the recovery ward and appears ready to break into a sprint after booking its sixth straight quarterly profit and making a deal to strengthen the drugstore chain's foothold in the burgeoning health clinic market.

  • Flu drug stockpiles a waste of money: Report Thursday, 10 Apr 2014 | 6:27 AM ET

    The U.K. and U.S. governments spent millions stockpiling a flu drug that is no better than paracetamol, according to a new report.

  • Ultragenyx is now up around 150 percent from its IPO price. Its CEO Dr. Emil Kakkis provides insight on the development of its drugs, and just how committed the company is to treating patients with the diseases its drugs treat.

  • Pharmacy sales deliver March boost to drugstores Thursday, 3 Apr 2014 | 9:29 AM ET

    Comparable-store sales climbed 3.5 percent at Walgreen and less that 1 percent at Rite Aid Corp., the companies announced Thursday. Walgreen and Rite Aid are the nation's largest and third-largest drugstore chains, respectively, based on the number of stores.

  • FTI Consulting managing director Barbara Ryan provides insight on new drugs showing dramatic improvement in the standard of care for high cholesterol.

  • New class of cholesterol drugs     Monday, 31 Mar 2014 | 1:19 PM ET

    CNBC's Dominic Chu reports on news out about a special new drug that could combat cholesterol.

  • CNBC's Steve Liesman reports how participants of CNBC's All-America Economic Survey view Obamacare, and raising the minimum wage.

  • CNBC's All-America survey: Marijuana views     Wednesday, 26 Mar 2014 | 1:22 PM ET

    CNBC's Steve Liesman reports 56 percent of participants supported the legalization of marijuana in their town.

  • Why drug treatment prices vary     Wednesday, 26 Mar 2014 | 1:08 PM ET

    The U.S. government is prohibited by law from negotiating drug prices, reports CNBC's Sheila Dharmarajan.

  • NJ pot bill: Garden State going green?     Tuesday, 25 Mar 2014 | 11:32 AM ET

    Senator Nicholas Scutari, D-N.J., discusses the bill he introduced that would allow adults to purchase and grow a limited amount of marijuana for personal use in New Jersey.

  • March 25- Walgreen Co, operator of the largest U.S. drugstore chain, on Tuesday reported a rise in quarterly sales but said a slowdown in the introduction of higher-profit generic medicines cut into its gross profit margin.

  • The group sent a letter on Sunday to chief executive officers of Wal-Mart Stores Inc, supermarket operators Kroger Co, Safeway Inc, which operate pharmacies, and drugstore chains Walgreen Co and Rite Aid Corp.. Wal-Mart, Walgreen, Rite Aid and Kroger all said they were reviewing the letter, while Safeway did not respond to requests for comment.

  • The companies receiving a letter on Sunday from the group were Wal-Mart Stores Inc, supermarket operators Kroger Co, Safeway Inc, which operate pharmacies, and drugstore chains Walgreen Co and Rite Aid Corp..

  • ADHD big money for big pharma     Wednesday, 12 Mar 2014 | 2:49 PM ET

    CNBC's Sheila Dharmarajan reports 15 percent of high school aged children are diagnosed with ADHD, or attention deficit hyperactivity disorder.

  • Doctor concerned about ADHD misdiagnosis     Wednesday, 12 Mar 2014 | 2:48 PM ET

    Dr. Richard Saul wrote a book called "ADHD Does Not Exist." Saul is certain attention ADHD, or attention deficit hyperactivity disorder exists only in its symptoms. The condition does not exist.

  • Deep discounting eats into Costco's holiday profit Thursday, 6 Mar 2014 | 9:55 AM ET
    A Costco store in Alhambra, Calif.

    Costco Wholesale's profit fell 15 percent, missing estimates, hurt by weaker gross margins in its fresh-food business and some non-foods merchandises.

  • Discussing the regulations for affordable medicine, with Mylan CEO Heather Bresch. She also discusses growth strategies for the company.

  • Starbuds of Denver owner Brian Ruden says the next step in his business is to get more "growth capacity" to handle the demand.

  • InterMune CEO: Drug trials bring hope     Tuesday, 25 Feb 2014 | 2:21 PM ET

    InterMune president & CEO Dan Welch says positive drug trial results bring hope to patients with idiopathic pulmonary fibrosis, and discusses the volatility in its stock.

Most Popular Video

Wednesday, 16 Apr 2014 | 11:56 AM ET

Art Cashin, UBS director of floor operations, explains what played into yesterday's market reversal and tells what sectors are back in favor today.

Wednesday, 16 Apr 2014 | 12:25 PM ET

CNBC's Steve Liesman provides insight into the highlights of Fed Chair Janet Yellen's comments at The Economic Club of New York.

Wednesday, 16 Apr 2014 | 12:15 PM ET

Josh Spencer, T. Rowe Price portfolio manager, encourages investors to get some guts and buy into growth stocks like Tesla and Amazon. He shares his opinions on some of the old tech names.